Perspective Therapeutics, Inc. (CATX) › Operating IncomePerspective Therapeutics, Inc. (CATX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$2.96M2012: -$3.60M2013: -$4.07M2014: -$4.59M2015: -$4.34M2016: -$5.08M2017: -$6.31M2018: -$6.73M2019: -$5.25M2020: -$3.48M2021: -$3.45M2022: -$8.67M2023: -$40.94M2024: -$90.89M2025: -$113.56M-$113.56M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$113.56M-25.0%2024-$90.89M-122.0%2023-$40.94M-372.1%2022-$8.67M-151.7%2021-$3.45M+0.9%2020-$3.48M+33.8%2019-$5.25M+21.9%2018-$6.73M-6.7%2017-$6.31M-24.1%2016-$5.08M-17.2%2015-$4.34M+5.5%2014-$4.59M-12.8%2013-$4.07M-13.0%2012-$3.60M-21.4%2011-$2.96M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share